P Kekäläinen Selected Research

P Kekäläinen Research Topics

3	Type 2 Diabetes Mellitus (MODY) 10/2000 - 01/2000
2	Insulin Resistance 08/2001 - 10/2000
1	Adrenocortical Adenoma (Disease, Conn's) 08/2003
1	Paraganglioma (Paragangliomas) 08/2003
1	Glucose Intolerance 08/2001
1	Hypertension (High Blood Pressure) 10/2000
1	Dyslipidemias (Dyslipidemia) 10/2000
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2000

2	Glucose (Dextrose)FDA LinkGeneric 08/2001 - 10/2000
1	3-Iodobenzylguanidine (Iobenguane)IBA 08/2003
1	Uric Acid (Urate)IBA 10/2000
1	VLDL CholesterolIBA 10/2000
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2000
1	oxidized low density lipoproteinIBA 10/2000
1	C-PeptideIBA 10/2000
1	HDL LipoproteinsIBA 10/2000
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2000
1	VLDL LipoproteinsIBA 10/2000
1	Triglycerides (Triacylglycerol)IBA 10/2000
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2000
1	Hepatocyte Nuclear FactorsIBA 10/2000
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 10/2000
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2000
1	RNA Splice SitesIBA 01/2000
1	NucleotidesIBA 01/2000
1	Insulin (Novolin)FDA Link 01/2000
1	Amino Acids FDA Link 01/2000
1	Sulfonylurea ReceptorsIBA 01/2000